Principal results of a randomised open label exploratory,...

Main
2019 / 7
Principal results of a randomised open label exploratory,...

EBioMedicine 2019 / 7

Principal results of a randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with a 12 h regimen of N-acetylcysteine for paracetamol overdose (POP trial)

Morrison, Emma E., Oatey, Katherine, Gallagher, Bernadette, Grahamslaw, Julia, O'Brien, Rachel, Black, Polly, Oosthuyzen, Wilna, Lee, Robert J., Weir, Christopher J., Henriksen, Dennis, Dear, James W.

How much do you like this book?

What’s the quality of the file?

Download the book for quality assessment

What’s the quality of the downloaded files?

Language:

english

Journal:

EBioMedicine

DOI:

10.1016/j.ebiom.2019.07.013

Date:

July, 2019

File:

PDF, 653 KB

english, 2019

Conversion to is in progress

Conversion to is failed

Principal results of a randomised open label exploratory,...

Principal results of a randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with a 12 h regimen of N-acetylcysteine for paracetamol overdose (POP trial)

Principal results of a randomised open label exploratory, safety and tolerability study with calmangafodipir in patients treated with a 12 h regimen of N-acetylcysteine for paracetamol overdose (POP trial)